A space for sharing and discussing news related to global current events, technology, and society.
69604 Members
We'll be adding more communities soon!
© 2020 Relevant Protocols Inc.
A space for sharing and discussing news related to global current events, technology, and society.
69604 Members
We'll be adding more communities soon!
© 2020 Relevant Protocols Inc.
Relevant
Hot
New
Spam
Relevant
Hot
New
Spam
0
19.2
0
19.2
Novavax Inc’s coronavirus vaccine was 96% effective in preventing cases caused by the original version of the coronavirus in a late-stage trial conducted in the United Kingdom, the company said on Thursday, moving it a step closer to regulatory approval.
Novavax Inc’s coronavirus vaccine was 96% effective in preventing cases caused by the original version of the coronavirus in a late-stage trial conducted in the United Kingdom, the company said on Thursday, moving it a step closer to regulatory approval.
Some low-ranking comments may have been hidden.
Some low-ranking comments may have been hidden.